Neuropace Inc (NPCE NASDAQ) stock market data APIs
$13.2089
0.27(2%)
as of March 27, 2026
Try our APIs with
free plan!
Neuropace Inc Financial Data Overview
Price chart is built with
Anychart
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Prev. Close
13.2089
Open
13.4825
High
13.7368
Low
13.1427
52 wk Range
7.5625-18.975
Market Cap
449 M
Shares Outstanding
33 667 K
Revenue
99 986 K
EPS
-0.08
Beta
1.865
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Neuropace Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Neuropace Inc data using free add-ons & libraries
Get Neuropace Inc Fundamental Data
Neuropace Inc Fundamental data includes:
- Net Revenue: 99 986 K
- EBITDA: -16 100 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-10
- EPS/Forecast: -0.1919
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neuropace Inc News
New
How The NeuroPace (NPCE) Story Is Shifting As Analysts Refresh Valuation Assumptions
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. NeuroPace is back on investor radar as analysts update thei...
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
NeuroPace, Inc. NPCE enters 2026 after posting $100 million in 2025 revenue, up 25% year over year. The business is also moving toward a cleaner mix, with the core RNS System taking center stage as no...
NPCE RNS System Explained: Growth Drivers and Setup for 2026
NeuroPace, Inc. NPCE is building a procedure-driven growth story around its RNS System, a brain-responsive implant designed to reduce seizures in adults with drug-resistant focal epilepsy. The company...
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
NeuroPace, Inc. NPCE is moving beyond a device-only story and leaning into software and workflow tools that aim to expand clinician capacity. The company is also pursuing an indication expansion that ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
